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Background:  A signiﬁcant  number  of patients  may  not  beneﬁt  from  conventional  techniques  of  myocardial
revascularization  due  to  diffuse  coronary  artery  disease  (CAD)  or small  coronary  arterial  sizes  because
of  smaller  arteries  causing  anastomotic  technical  difﬁculties  and  poor  run-off.  Diabetic  patients  have  a
more  severe  and  diffuse  coronary  atherosclerosis  with  smaller  coronary  arteries  limiting  the  possibility
to  perform  a successful  and  complete  revascularization,  but  this  has  not  been  examined  in  prediabetics.
Objective:  To  evaluate  whether  there  is an  association  between  prediabetes  and  the  coronary  arterial  size.
Methods:  We prospectively  studied  168  consecutive  patients  with  CAD  and 172 patients  with  normal
coronary  artery  anatomy  (NCA).  Patients  were  divided  into  three  groups  according  to  hemoglobin  (Hb)
A1c  levels  as “normal,”  “prediabetic,”  and  “diabetic”  groups,  and  the coronary  artery  sizes  and  Gensini
scores  were  analyzed.
Results: There  were  78  female  patients  and  90  male  patients  in  the  CAD  group, and  87  female  patients
and  85  male  patients  in the NCA  group.  There  was  a statistically  signiﬁcant  difference  in distal  and
proximal  total  coronary  arterial  size  among  the  CAD  and  NCA  groups  for both  genders.  There  was  a
positive  correlation  between  the HbA1c  subgroups  and  Gensini  score  (Spearman’s  :  0.489,  p <  0.001  in
female  group;  Spearman’s  :  0.252  p  = 0.016  in  male  group).
Conclusion: We  found  that prediabetic  patients  have  a smaller  coronary  size  and diffuse  coronary  nar-
rowing  for  both  genders,  particularly  in  distal  coronary  arterial  tree  of  left  anterior  descending  coronary
artery.  The  early  detection  of  prediabetes  in  daily  cardiology  practice  may  provide  more  appropriate
coronary  lesion  for  percutaneous  or  surgical  revascularization.
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Cardiovascular diseases are the leading cause of morbidity and
ortality in insulin-resistant individuals with glycemic disorders.
he risk for death among people with diabetes is about twice
hat of people of similar age but without diabetes [1,2]. How-
ver, epidemiologic evidence suggests this morbidity–mortality
elationship  begins early in the progression from normal glucose
olerance to overt diabetes. Since both increased insulin resistance
nd impaired -cell function are present long before overt hyper-
lycemia becomes evident, indeed, most diabetic patients already
how signs of cardiovascular disease upon diagnosis [1,2]. Overt
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diabetes is usually preceded by a condition known as “prediabetes,”
which refers to an intermediate stage in which individuals have
blood glucose or glycated hemoglobin (hemoglobin A1c, HbA1c)
levels higher than normal but not high enough to be classiﬁed as
diabetes [2]. Subjects with prediabetes have an increased risk for
future overt diabetes with a conversion rate of ∼5–10% per year
[3,4]. This risk increase has found to be a continuum and begins
at a level below the cut point for impaired fasting glucose (IFG,
100 mg/dl) [5]. The prevalence of diabetes and prediabetes is sub-
stantial among adults with coronary artery disease (CAD) and likely
underestimated because of suboptimal screening [6,7]. In 2010, the
American Diabetes Association (ADA) proposed a “diabetes” diag-
nosis based on an HbA1c ≥ 6.5%, and ‘prediabetes’ [including IFG or
impaired glucose tolerance (IGT)] as an HbA1c 5.7–6.4% [2].
Diabetic  patients have a more severe, extensive-diffuse and
rapidly progressive form of coronary atherosclerosis with an unfa-
vorable angiographic anatomy limiting the possibility to perform
vier Ltd. All rights reserved.
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 successful and complete revascularization [3,8–10]. Compared
o those without diabetes, diabetics have had worse outcomes
ith percutaneous transluminal coronary angioplasty, bare-metal
tents, and drug-eluting stents. The reasons for this trend are
ecause patients with diabetes have smaller-caliber vessels, a dif-
use disease that often progresses rapidly, a greater burden of
therosclerotic disease, and exaggerated neointimal hyperplasia.
atients with small vessels present a higher risk for an adverse
utcome after percutaneous coronary intervention (PCI) [10,11],
ecause of a higher incidence of restenosis and an increased risk
f major adverse cardiac events [12,13] and a higher risk after
oronary artery bypass grafting (CABG) due to more technically
hallenging operative procedures and lower long-term patency
ates [14–17] due to difﬁculties in anastomoses between saphenous
ein grafts or internal mammary conduits to small caliber native
oronary arteries particularly in diabetics [18] or women [19–21].
n the Coronary Artery Surgery Study, small body size and coro-
ary artery caliber were the strongest predictors of perioperative
ortality [22].
In  general, CAD in diabetic patients is detected at an advanced
tage, whereas the disease in its premature (prediabetes) or
symptomatic stages (undiagnosed diabetics) remains unfortu-
ately undetected [23,24]. Such observations impose an aggressive
pproach to diagnostic strategies in diabetic patients to detect
AD at an early asymptomatic stage, which is probably charac-
erized by a more favorable coronary vessel anatomy. Despite the
emarkable advances in revascularization strategies made during
he past decade, a signiﬁcant proportion of patients are excluded
rom either PCI or CABG because of unsuitable or ungraftable coro-
ary anatomy including diffuse severe CAD, extremely calciﬁed
essels, chronic total occlusions, or small vessel caliber. In diabetics,
he coronary arteries and their branches have been shown to have
maller diameters than normal subjects [25,26], but also appear
o be narrower in prediabetic patient in daily cardiology practice.
e aimed to evaluate whether there was an association between
rediabetes and diffuse coronary narrowing and/or coronary artery
izes.
ethods
We planned to compare the coronary artery sizes separately
n patients with normal coronary artery (NCA) ﬁndings in all 3
ajor epicardial and the left main coronary arteries, and patients
ith CAD. We  prospectively studied 172 consecutive patients with
CA anatomy, and 168 consecutive CAD patients referred for
lective coronary angiography. Those with known valvular heart
isease, congenital heart disease, chronic kidney disease, anemia,
r hemoglobinopathies were excluded from the study [27–29].
atients were classiﬁed according to HbA1c levels in accordance
ith 2010 ADA Guidelines [2] into three groups: HbA1c lower than
.7% (normal control group), HbA1c: 5.7–6.4% (prediabetic group),
nd HbA1c higher than 6.4% (diabetic group), and the coronary
rtery sizes and Gensini scores were analyzed. All measurements
ere performed by the same cardiology specialist blinded to the
ubjects’ clinical and laboratory status.
Fasting blood specimens were collected to measure fasting
lasma glucose (FPG), lipid proﬁle, creatinine, and HbA1c lev-
ls. Other risk factors for cardiovascular disease and demographic
arameters (age, gender, and body mass index) at the moment
f enrollment in the study were evaluated by history-taking and
hysical examination results.Selective coronary angiography was performed with the
tandard Judkins approach. Signiﬁcant CAD was deﬁned as the
resence of >50% luminal diameter narrowing of one or more
ajor epicardial arteries or its major branches. Segments of eachiology 63 (2014) 29–34
epicardial  coronary artery were measured in locations deﬁned by
Dodge et al. [30] and Mosseri et al. [25] as follows:
(a) The left main artery (LM) was measured at its midpoint,
(b) the left anterior descending artery (LAD) was  divided into three
segments,  the proximal LAD (pLAD) was measured at its mid-
point  between its origin and the ﬁrst branch (ﬁrst septal-1S or
diagonal-1D)  of the pLAD, the mid-LAD (mLAD) was measured
between 1S and 1D, and the distal LAD (dLAD) was measured
after  the diagonal branch of the LAD, apical LAD was mea-
sured  in its distal 1.0 cm before the distal bifurcation, commonly
referred to as the “pitchfork,” “moustache,” or “whale’s tail”,
(c) the circumﬂex (Cx) was  also divided into two segments, the
proximal  Cx (pCx) was measured at its midpoint between its
origin  and the ﬁrst obtuse marginal (1 M),  the distal Cx (dCx)
was  measured at the origin of the second obtuse marginal
branch (2 M);  and ﬁnally the 1 M was measured at its origin,
(d)  the right coronary artery (RCA) was  divided into two seg-
ments:  the proximal RCA (pRCA) was  measured 15 mm from the
ostium and the distal RCA (dRCA) was  measured at the ostium
of  the posterior descending artery (PDA). In the CAD group,
measurements of artery size were done on the most proxi-
mal  disease-free part of each segment. In this respect, totally
occluded segments were not evaluated in statistical analysis.
Intracoronary nitrate was  not administered to patients before
the  coronary angiography. Quantitative coronary angiographic
analysis of all three coronary arteries was  performed using the
edge-detection method. The diameter of the catheter after con-
trast  ﬁlling was  used as a reference for calculating true arterial
diameters. Measurements were taken in two orthogonal views
for  each of the major epicardial coronary arteries. The average
of  the two measurements was used for each coronary artery.
The sum of the pLAD, pCx, and pRCA was  calculated and
deﬁned as total proximal coronary diameter (pTCD). The sum
of diameters of the distal segments including dLAD, dCx, and
dRCA was calculated and deﬁned as total distal coronary diameter
(dTCD).
The SPSS statistical software package (version 16.0; SPSS Inc.,
Chicago, IL, USA) was used to perform all statistical calculations.
Continuous variables were expressed as mean ± SD. Since the
coronary diameters in men  are greater than women  [31], all com-
parisons were made separately for both genders. The analysis of
variance (ANOVA) with post hoc Tukey’s HSD or Chi-square test
was used for the statistical analysis of the results. Relationships
between the continuous variables were evaluated by Pearson’s
correlation analysis when data were normally distributed or by
Spearman’s correlation analysis when they were not normally
distributed. For all tests, a value of p < 0.05 was  considered signiﬁ-
cant.
Results
There were 78 female patients and 90 male patients in the CAD
group (Table 1) and 87 female patients and 85 male patients in the
NCA group (Table 2). There were no statistically signiﬁcant differ-
ences at baseline in any demographic or baseline variables between
the groups (Tables 1 and 2). There were statistically signiﬁcant dif-
ferences in proximal and distal total coronary arterial sizes between
the CAD (Table 1) and NCA (Table 2) groups for both genders partic-
ularly in LAD. There was  a positive correlation between the patient
subgroups (diabetic, prediabetic, and normal groups) and Gensini
score (Spearman’s : 0.489, p < 0.001 in the female group; Spear-
man’s : 0.252, p = 0.016 in the male group).
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Table  1
Comparison of the coronary sizes among patients with coronary artery disease. BMI, body mass index; LDL, low density lipoprotein; LMCA, left mean coronary artery;
Prox-LAD, proximal left anterior descending artery; OM1, obtus marginal; RCA, right coronary artery; PDA, posterior descending artery; TCD, total coronary diameter.
Groups Diabetes (HbA1c > 6.4) Prediabetes (HbA1c: 5.7–6.4) Normal (HbA1c < 5.7) p value
Female (n = 32) (n = 22) (n = 24)
Age (year) 60.8 ± 7.3 57.5 ± 8.4 57.5 ± 8.0 0.190
BMI  (kg/m2) 32.8 ± 5.1 29.7 ± 3.6 31.6 ± 5.1 0.145
Family  history (%) 34% 59% 58% 0.058
Hypertension (%) 75% 50% 62% 0.167
Current  smoke (%) 19% 14% 37% 0.119
Creatinine  (mg/dl) 0.86 ± 0.18 0.77 ± 0.09 0.81  ± 0.11 0.118
LDL  cholesterol (mg/dl) 153.4 ± 39.7 158.0 ± 37.9 145.6 ± 30.4 0.844
Angiographic  ﬁndings
LMCA  (mm)  3.94 ± 0.64 4.29 ± 0.63 4.38 ± 0.63 0.028
Prox-LAD  (mm)  2.96 ± 0.34 3.26 ± 0.35 3.64 ± 0.46 <0.001
Mid-LAD  (mm)  2.39 ± 0.46 2.70 ± 0.33 3.13 ± 0.59 <0.001
Distal-LAD  (mm) 1.98 ± 0.40 2.18 ± 0.35 2.60  ± 0.55 <0.001
Apex (mm)  1.15 ± 0.44 1.20 ± 0.34 1.83 ± 0.42 <0.001
Prox-Cx  (mm) 2.62 ± 0.60 3.00 ± 0.58 3.27 ± 0.65 0.007
Distal-Cx  (mm) 2.19 ± 0.57 2.41 ± 0.56 2.52  ± 0.72 0.232
OM1-Cx (mm)  1.59 ± 0.51 1.82 ± 0.51 1.94 ± 0.59 0.022
Prox-RCA  (mm)  3.08 ± 0.53 3.29 ± 0.57 3.68 ± 0.82 0.160
Mid-RCA  (mm)  2.60 ± 0.50 2.85 ± 0.63 3.39 ± 0.80 0.012
PDA-RCA  (mm) 1.61 ± 0.29 1.96 ± 0.58 2.08 ± 0.53 0.011
Proximal  TCD (mm)  8.67 ± 1.20 9.54 ± 0.95 10.08 ± 1.32 <0.001
Distal  TCD (mm)  5.75 ± 0.88 6.55 ± 0.48 6.95 ± 0.98 <0.001
Gensini  score 62.5 ± 50.4 45.0 ± 29.8 33.1 ± 30.0 <0.001
Male  (n = 34) (n = 31) (n = 25)
Age (year) 60.4 ± 7.3 55.7 ± 7.7 58.1 ± 9.3 0.070
BMI  (kg/m2) 31.6 ± 4.8 31.2 ± 3.8 29.2 ± 3.4 0.075
Family  history (%) 26% 19% 40% 0.225
Hypertension (%) 47% 23% 40% 0.114
Current  smoke (%) 62% 65% 56% 0.806
Creatinine  (mg/dl) 0.88 ± 0.18 0.82 ± 0.16 0.94 ± 0.09 0.178
LDL  cholesterol (mg/dl) 136.5 ± 42.3 140.8 ± 26.6 145.6 ± 30.4 0.649
Angiographic  ﬁndings
LMCA  (mm)  4.00 ± 0.66 4.27 ± 1.09 4.55 ± 0.77 0.055
Prox-LAD  (mm) 3.01 ± 0.58 3.23 ± 0.83 3.70  ± 0.55 0.001
Mid-LAD  (mm)  2.59 ± 0.51 2.75 ± 0.65 3.15 ± 0.59 0.002
Distal-LAD  (mm)  2.06 ± 0.34 2.24 ± 0.56 2.60 ± 0.55 <0.001
Apex  (mm)  1.25 ± 0.47 1.45 ± 0.45 1.83 ± 0.42 <0.001
Prox-Cx  (mm) 2.78 ± 0.54 3.02 ± 0.96 3.27 ± 0.65 0.046
Distal-Cx  (mm) 2.28 ± 0.45 2.46 ± 0.76 2.52 ± 0.72 0.325
OM1-Cx  (mm)  1.75 ± 0.53 1.91 ± 0.72 1.94 ± 0.59 0.442
Prox-RCA  (mm) 3.19 ± 0.72 3.44 ± 0.73 3.68  ± 0.82 0.053
Mid-RCA  (mm)  2.81 ± 0.75 2.85 ± 0.63 3.39 ± 0.80 0.006
PDA-RCA  (mm) 1.65 ± 0.46 1.73 ± 0.42 2.08 ± 0.53 0.002
Proximal  TCD (mm)  8.98 ± 1.30 9.69 ± 1.82 10.65 ± 1.67 0.047
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Gensini  score 51.4 ± 33.3 43.
iscussion
In the present study, prediabetes was found to be associated
ith diffuse coronary narrowing and small vessel disease particu-
arly in distal coronary arteries for both genders, particularly in the
AD (Tables 1 and 2). Since patients with small vessels present a
igher risk for an adverse outcome after PCI [10,11] or CABG espe-
ially in the LAD coronary artery [14–17], this ﬁnding is particularly
mportant for early detection of prediabetes in daily cardiology
ractice.
The role of cardiologists in the management of patients with
iabetes is evolving owing to the close relationship between dia-
etes and CAD. Indeed, a large percentage of patients with diabetes
resent with a ﬁrst coronary event before their diabetes are diag-
osed. Therefore, because the cardiologist often may  be the ﬁrst
linician to diagnose a patient with diabetes, it is incumbent
pon practitioners of this specialty to understand the disease pro-
ess and the interventions necessary to improve outcomes [32].
he worldwide increase in the incidence of diabetes and predia-
etes as a result of global dietary changes and reduced physical0 7.20 ± 1.41 0.025
.0 33.1 ± 20.2 0.040
activity  should be of special concern to cardiologists and patient
management necessitates transprofessional collaboration between
cardiologists and diabetologists to be successfully accomplished
[33]. The early detection of prediabetes may also provide more
appropriate coronary lesions for percutaneous or surgical revascu-
larization and identiﬁes people at highest risk of developing overt
diabetes and CAD [34].
Traditionally,  diagnosis of diabetes was based on symptoms due
to hyperglycemia, but during the past decades much emphasis has
been placed on the need to identify diabetes and other forms of glu-
cose abnormalities such as prediabetes in asymptomatic subjects
[3,4]. All things considered, it is clear that that prediabetes is not a
benign condition [35–42]. In addition to the risk of progression to
overt diabetes, prediabetes has been reported to increase the risk
for certain microvascular and macrovascular complications that are
typically associated with diabetes [3,35,36]. Evidence suggests that
most diabetic patients have the condition for between 9 and 12
years before the diagnosis [37] and about 50% of patients already
have diabetic tissue damage such as retinopathy, heart disease, or
microalbuminuria at the time they are diagnosed [38]. The risk for
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Table  2
Comparison of the coronary sizes among patients with angiographically normal coronary arteries. BMI, body mass index; LDL, low density lipoprotein; LMCA, left mean
coronary artery; Prox-LAD, proximal left anterior descending artery; OM1, obtus marginal; RCA, right coronary artery; PDA, posterior descending artery; TCD, Total coronary
diameter.
Groups Diabetes (HbA1c > 6.4) Prediabetes (HbA1c:5.7–6.4) Normal (HbA1c < 5.7) p value
Female (n = 31) (n = 26) (n = 30)
Age  (year) 58.4 ± 8.3 58.1 ± 8.1 56.1 ± 7.9 0.486
BMI  (kg/m2) 34.2 ± 5.2 32.4 ± 4.7 32.9 ± 7.8 0.489
Family  history (%) 13% 31% 17% 0.211
Hypertension (%) 52% 50% 33% 0.292
Current  smoke (%) 7% 23% 13% 0.193
Creatinine  (mg/dl) 0.73  ± 0.16 0.67 ± 0.13 0.68 ± 0.13 0.194
LDL  cholesterol (mg/dl) 132.4 ± 30.6 148.5 ± 33.9 141.2 ± 28.3 0.194
Angiographic  ﬁndings
LMCA  (mm)  3.91 ± 0.66 3.90 ± 0.61 4.26 ± 0.94 0.127
Prox-LAD  (mm)  3.14 ± 0.48 3.29 ± 0.57 3.61 ± 0.75 0.012
Mid-LAD  (mm) 2.64  ± 0.62 2.65  ± 0.61 3.00 ± 0.61 0.039
Distal-LAD  (mm)  1.99 ± 0.58 2.14 ± 0.50 2.43 ± 0.47 0.006
Apex  (mm) 1.14 ± 0.48 1.11 ± 0.37 1.36 ± 0.32 0.031
Prox-Cx  (mm) 2.83  ± 0.55 3.03  ± 0.54 3.25 ± 0.74 0.039
Distal-Cx  (mm)  2.29 ± 0.46 2.50 ± 0.51 2.60 ± 0.68 0.102
OM1-Cx  (mm)  1.71 ± 0.52 1.57 ± 0.43 1.79 ± 0.71 0.348
Prox-RCA  (mm)  3.31 ± 0.62 3.52 ± 0.87 3.56 ± 0.44 0.303
Mid-RCA  (mm)  2.91 ± 0.49 3.22 ± 0.49 3.16 ± 0.79 0.125
PDA-RCA  (mm) 1.62 ± 0.46 1.99 ± 0.38 1.99 ± 0.59 0.004
Proximal  TCD (mm)  9.28 ± 1.32 9.88 ± 1.15 10.38 ± 2.04 0.028
Distal  TCD (mm) 5.90  ± 1.17 6.64  ± 0.91 7.01 ± 1.28 0.001
Male  (n = 28) (n = 28) (n = 29)
Age  (year) 53.5 ± 6.3 54.4 ± 8.5 54.8 ± 9.4 0.824
BMI  (kg/m2) 32.1 ± 5.9 30.6 ± 2.3 29.7 ± 3.8 0.081
Family  history (%) 36% 18% 41% 0.140
Hypertension (%) 43% 18% 38% 0.108
Current  smoke (%) 46% 36% 48% 0.589
Creatinine  (mg/dl) 0.89 ± 0.17 0.93 ± 0.14 0.84 ± 0.15 0.101
LDL  cholesterol (mg/dl) 140.4 ± 47.3 126.8 ± 35.7 133.2 ± 37.7 0.471
Angiographic  ﬁndings
LMCA  (mm)  4.03 ± 0.89 4.36 ± 1.06 4.60 ± 0.89 0.081
Prox-LAD  (mm) 3.34  ± 0.60 3.56  ± 0.61 3.84 ± 0.80 0.025
Mid-LAD  (mm)  2.69 ± 0.64 3.06 ± 0.58 3.31 ± 0.78 0.003
Distal-LAD  (mm)  2.19 ± 0.56 2.43 ± 0.50 2.73 ± 0.69 0.004
Apex  (mm) 1.36 ± 0.47 1.34 ± 0.35 1.67 ± 0.51 0.012
Prox-Cx  (mm)  3.10 ± 0.58 3.31 ± 0.70 3.51 ± 0.69 0.066
OM1-Cx  (mm)  1.82 ± 0.48 1.87 ± 0.64 2.07 ± 0.80 0.324
Distal-Cx  (mm)  2.57 ± 0.62 2.42 ± 0.61 2.96 ± 0.76 0.008
Prox-RCA  (mm) 3.68  ± 0.81 3.80  ± 0.70 3.82 ± 1.05 0.800
Mid-RCA  (mm)  3.30 ± 0.81 3.34 ± 0.78 3.46 ± 1.11 0.798
PDA-RCA  (mm) 2.01 ± 0.50 2.16 ± 0.52 2.10 ± 0.77 0.651
.67 ± 
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iabetic retinopathy has been found to be highest at an HbA1c level
f 6.0–6.4% for whites and 5.5–5.9% for blacks [39]. Data from the
urses’ Health Study [40] suggest that women destined to develop
iabetes experienced a 3-fold increased risk of cardiovascular dis-
ase 10–15 years before the onset of diabetes, corroborating the
ypothesis that the “clock starts ticking” very early [41–43].
All  these studies showing increased risks for glycemic pro-
ression and microvascular and macrovascular complications in
rediabetes strengthen the rationale for early intervention and
etection of diabetes in its premature stage. There is a need to
implify screening tests for glycemic disorders so patients can be
dentiﬁed earlier and more efﬁciently. Growing evidence strongly
uggests that the assessment of HbA1c levels has advantages
ver measurement of glucose levels or oral glucose tolerance test
OGTT) in predicting the risk of developing diabetes or CAD [3,44].
he HbA1c result reﬂects longer term glycemia and is less affected
y recent physical/emotional stress. Appointments do not need to
e limited to the morning also. However, there is some debate as
o whether HbA1c should replace FPG or the OGTT [3,45,46]. As the
wo tests detect different people, some individuals with diabetes
etected on OGTT will no longer be classiﬁed as having type 21.61 11.18 ± 1.85 0.059
.11 7.79 ± 1.36 0.007
diabetes  using HbA1c ≥6.5% criteria. Kumaravel et al. reported
that current ADA deﬁnitions of prediabetes based on HbA1c would
fail to detect almost 40% of people currently classiﬁed as IFG [45].
More recent studies have shown that HbA1c may  be insensitive
in diagnosing IFG and IGT, with sensitivities ranging from 27%
to 47% [46]. Furthermore, some medical conditions can result in
HbA1c assay measurements not reﬂecting glycemic control over
the previous 2–3 months; these include hematological disorders,
renal failure, and chronic excess alcohol consumption. Although
there is still some debate, HbA1c has been recommended in 2010
by the ADA as a diagnostic tool for detecting type diabetes and
prediabetes [2]. Efﬁcacy of the new HbA1c 5.7–6.4% criterion will
improve as a screening test and will be more predictive when used
with IFG criterion for identiﬁcation of individuals at substantially
increased risk of developing diabetes [2]. Using both HbA1c and IFG
for screening together could increase diagnostic accuracy [2,47].
Previous  studies have reported that female gender is associated
with worse clinical and revascularization outcomes following coro-
nary revascularization compared to men  [19,31,32]. The observed
less favorable clinical outcomes in women  may  be due to smaller
vessel size in women. On average, women  have proximal coronary
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rteries that were 0.30 mm smaller than men  in previous stud-
es [32,48]. The smaller coronary artery vessel size in women may
xplain some, but not all excess gender-related risk with coronary
rtery revascularization [27,29].
Several limitations should be considered. Firstly, this study is
imited by its cross-sectional nature of patients referred for coro-
ary angiography and its results may  not be generalizable to the
opulation as a whole. Secondly, the effect of factors that might
hange HbA1c levels independently of glycemia, such as anemia,
r hemoglobinopathies, should be considered. A third possible lim-
tation was the lack of intravascular ultrasound usage. It must
lways be remembered that a coronary angiogram is a “lumino-
ram” and cannot be used to assess changes in wall thickness, a
ardinal feature of atherosclerosis. With the use of traditional coro-
ary angiography, diffuse atherosclerosis and positive remodeling
hat may  not be apparent with lumen-limited angiography may
reclude accurate measurement of the true vessel wall dimensions,
ecause the normal size of the coronary artery for its distal myocar-
ial bed size is not known and cannot be measured directly with
iffuse involvement of the artery, therefore, intravascular ultra-
ound could be a more effective method [49]. The other main
imitation of the study included the inability to examine the effect
f the duration of a speciﬁc HbA1c level. Again, we  only included
atients with completely normal creatinine levels. The higher cre-
tinine levels in diabetics could have been affected by the coronary
rtery sizes.
In  conclusion, we found that the prediabetes was  associated
ith diffuse coronary narrowing and small vessel disease. Since
mall vessel disease has a higher risk for an adverse outcome after
CI because of a higher incidence of restenosis and after CABG
ecause of smaller arteries causing anastomotic technical difﬁcul-
ies and poor run-off, this ﬁnding is particularly important for early
etection of prediabetes in daily cardiology practice, which may
rovide more appropriate coronary lesions for percutaneous or sur-
ical revascularization. Cardiologists must be aware of these trends
nd understand the inﬂuence of prediabetes on CAD.
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